Ala‐Eddin Al Moustafa

3.2k total citations
82 papers, 2.4k citations indexed

About

Ala‐Eddin Al Moustafa is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Ala‐Eddin Al Moustafa has authored 82 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 35 papers in Molecular Biology and 22 papers in Epidemiology. Recurrent topics in Ala‐Eddin Al Moustafa's work include Cervical Cancer and HPV Research (19 papers), Viral-associated cancers and disorders (13 papers) and HER2/EGFR in Cancer Research (9 papers). Ala‐Eddin Al Moustafa is often cited by papers focused on Cervical Cancer and HPV Research (19 papers), Viral-associated cancers and disorders (13 papers) and HER2/EGFR in Cancer Research (9 papers). Ala‐Eddin Al Moustafa collaborates with scholars based in Canada, Qatar and Syria. Ala‐Eddin Al Moustafa's co-authors include Amber Yasmeen, Moulay A. Alaoui‐Jamali, Gerald Batist, Semir Vranić, Lily Yen, Ishita Gupta, Saghir Akhtar, William D. Foulkes, Robin Augustine and Anwarul Hasan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Oncogene.

In The Last Decade

Ala‐Eddin Al Moustafa

79 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ala‐Eddin Al Moustafa Canada 27 881 798 461 337 238 82 2.4k
Yi Zeng China 26 863 1.0× 1.0k 1.3× 409 0.9× 594 1.8× 283 1.2× 78 2.9k
Yuchen Zhang China 27 574 0.7× 977 1.2× 241 0.5× 269 0.8× 238 1.0× 134 2.4k
Yong Fang China 29 732 0.8× 1.3k 1.6× 397 0.9× 365 1.1× 80 0.3× 128 2.5k
Manash K. Paul United States 26 715 0.8× 1.3k 1.7× 139 0.3× 364 1.1× 243 1.0× 72 3.0k
Lisong Teng China 33 968 1.1× 1.4k 1.7× 256 0.6× 758 2.2× 160 0.7× 170 3.7k
Yao‐Ching Hung Taiwan 33 428 0.5× 763 1.0× 362 0.8× 286 0.8× 113 0.5× 100 2.6k
Shusen Zheng China 29 845 1.0× 826 1.0× 338 0.7× 235 0.7× 457 1.9× 117 3.0k
Dongqing Zuo China 21 397 0.5× 787 1.0× 188 0.4× 323 1.0× 103 0.4× 45 1.6k
Lei Yu China 32 982 1.1× 1.1k 1.4× 197 0.4× 240 0.7× 495 2.1× 104 2.7k

Countries citing papers authored by Ala‐Eddin Al Moustafa

Since Specialization
Citations

This map shows the geographic impact of Ala‐Eddin Al Moustafa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ala‐Eddin Al Moustafa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ala‐Eddin Al Moustafa more than expected).

Fields of papers citing papers by Ala‐Eddin Al Moustafa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ala‐Eddin Al Moustafa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ala‐Eddin Al Moustafa. The network helps show where Ala‐Eddin Al Moustafa may publish in the future.

Co-authorship network of co-authors of Ala‐Eddin Al Moustafa

This figure shows the co-authorship network connecting the top 25 collaborators of Ala‐Eddin Al Moustafa. A scholar is included among the top collaborators of Ala‐Eddin Al Moustafa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ala‐Eddin Al Moustafa. Ala‐Eddin Al Moustafa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Merhi, Maysaloun, Monika Ulamec, Melita Perić Balja, et al.. (2025). Neratinib and metformin: A novel therapeutic approach against HER2-Positive Breast Cancer. Biomedicine & Pharmacotherapy. 187. 118034–118034.
2.
Pedersen, Shona, Amr Mohamed, Ala‐Eddin Al Moustafa, et al.. (2025). Proteomic analysis reveals potential biomarker candidates in serous ovarian tumors – a preliminary study. Współczesna Onkologia. 29(1). 77–92. 1 indexed citations
3.
Kassab, Amal, Ishita Gupta, & Ala‐Eddin Al Moustafa. (2023). Role of E2F transcription factor in oral cancer: Recent insight and advancements. Seminars in Cancer Biology. 92. 28–41. 34 indexed citations
4.
Gupta, Ishita, Hanan Farghaly, Semir Vranić, et al.. (2022). Incidence of HPVs, EBV, and MMTV-Like Virus in Breast Cancer in Qatar. Intervirology. 65(4). 188–194. 10 indexed citations
5.
Rachid, Ousama, et al.. (2021). Emerging innate biological properties of nano-drug delivery systems: A focus on PAMAM dendrimers and their clinical potential. Advanced Drug Delivery Reviews. 178. 113908–113908. 105 indexed citations
6.
Moustafa, Ala‐Eddin Al, et al.. (2020). A comprehensive review on the antiviral activities of chalcones. Journal of drug targeting. 29(4). 403–419. 99 indexed citations
7.
Al‐Asmakh, Maha, Hiba Bawadi, Ishita Gupta, et al.. (2020). Dasatinib and PD-L1 inhibitors provoke toxicity and inhibit angiogenesis in the embryo. Biomedicine & Pharmacotherapy. 134. 111134–111134. 14 indexed citations
8.
Siddique, Abu Bakar, Farhan Cyprian, Khalid A. El Sayed, et al.. (2019). Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer. European Journal of Medicinal Chemistry. 187. 111954–111954. 42 indexed citations
9.
Moustafa, Ala‐Eddin Al, Hussain Gadelkarim Ahmed, Ali A. Sultan, & Gerburg M. Wulf. (2019). EBV-Associated Carcinomas: Presence, Role and Prevention Strategies. 2 indexed citations
10.
Aboulkassim, Tahar, et al.. (2018). Teucrium Polium Plant Extract Provokes Substantial Cytotoxicity at the Early Stage of Embryonic Development. SHILAP Revista de lepidopterología. 19(1). 67–71. 10 indexed citations
11.
Moustafa, Ala‐Eddin Al. (2013). Insulin-like growth factor-1 enhances mortality risk in women with breast cancer through epithelial-mesenchymal transition initiation. Clinical Cancer Investigation Journal. 2(3). 175. 1 indexed citations
12.
Yasmeen, Amber, et al.. (2013). Significant toxic role for single-walled carbon nanotubes during normal embryogenesis. Nanomedicine Nanotechnology Biology and Medicine. 9(7). 945–950. 36 indexed citations
13.
Alachkar, Amal, et al.. (2011). Teucrium polium plant extract provokes significant cell death in human lung cancer cells. Health. 3(6). 366–369. 14 indexed citations
14.
Alazzam, Anas, Ion Stiharu, Amal Kassab, et al.. (2010). Identification of deregulated genes by single wall carbon-nanotubes in human normal bronchial epithelial cells. Nanomedicine Nanotechnology Biology and Medicine. 6(4). 563–569. 29 indexed citations
15.
Moustafa, Ala‐Eddin Al, Amal Kassab, Andrew D. Darnel, & Amber Yasmeen. (2008). High-Risk HPV/ErbB-2 Interaction on E-Cadherin/Catenin Regulation in Human Carcinogenesis. Current Pharmaceutical Design. 14(22). 2159–2172. 28 indexed citations
16.
Yasmeen, Amber, Tarek A. Bismar, Hafedh Dekhil, et al.. (2007). ErbB-2 Receptor Cooperates with E6/E7 Oncoproteins of HPV Type 16 in Breast Tumorigenesis. Cell Cycle. 6(23). 2939–2943. 18 indexed citations
17.
Yasmeen, Amber, Abdel Hosein, Qunyan Yu, & Ala‐Eddin Al Moustafa. (2007). Critical role for D‐type cyclins in cellular transformation induced by E6/E7 of human papillomavirus type 16 and E6/E7/ErbB‐2 cooperation. Cancer Science. 98(7). 973–977. 10 indexed citations
18.
Yasmeen, Amber, Tarek A. Bismar, & Ala‐Eddin Al Moustafa. (2006). Erbb Receptors and Epithelial-Cadherin–Catenin Complex In Human Carcinomas. Future Oncology. 2(6). 765–781. 26 indexed citations
19.
Yen, Lily, Naciba Benlimame, Dingzhang Xiao, et al.. (2002). Differential Regulation of Tumor Angiogenesis by Distinct ErbB Homo- and Heterodimers. Molecular Biology of the Cell. 13(11). 4029–4044. 114 indexed citations
20.
Yen, Lily, Xiaoli You, Ala‐Eddin Al Moustafa, et al.. (2000). Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis. Oncogene. 19(31). 3460–3469. 189 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi Zeng Breakdown of academic impact, for papers by Yuchen Zhang Breakdown of academic impact, for papers by Yong Fang Breakdown of academic impact, for papers by Manash K. Paul Breakdown of academic impact, for papers by Lisong Teng Breakdown of academic impact, for papers by Yao‐Ching Hung Breakdown of academic impact, for papers by Shusen Zheng Breakdown of academic impact, for papers by Dongqing Zuo Breakdown of academic impact, for papers by Lei Yu
Rankless by CCL
2026